Company news
Bullfrog Ai Holdings, Inc. (NASDAQ:BFRG) news
Bullfrog Ai Holdings, Inc. news releases on 6ix. Latest, Oct 6, 2026: BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global…
Press releases & updates
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
October 6, 2026
BullFrog AI to Participate in September 2026 Investor Conferences
September 8, 2026
BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference
July 22, 2026
BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026
July 21, 2026
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
June 1, 2026
BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
April 22, 2026
BullFrog AI Announces Participation at AACR Annual Meeting
April 14, 2026
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
April 12, 2026
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
March 29, 2026
BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
March 24, 2026
BullFrog to Host Webinar on New Precision AI Capability
March 10, 2026
BullFrog AI to Unveil New Precision AI Capability
February 4, 2026
BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
January 27, 2026
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
January 6, 2026
BullFrog AI Publishes Annual Letter to Shareholders
December 30, 2025
BullFrog AI and Myriad Uranium Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
November 28, 2025
BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights
November 18, 2025
BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
November 12, 2025
BullFrog AI Announces Abstract Accepted for Presentation at 2026 ASCO Gastrointestinal Cancers Symposium
November 4, 2025
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30
October 30, 2025
BullFrog AI and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
October 24, 2025
BullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ Module
September 30, 2025
BullFrog AI and Sygnature Discovery Announce Official Sales Launch of BullFrog Data Networks™ to Global Biopharma Clients
September 25, 2025
BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar
September 23, 2025
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
September 8, 2025
BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference
July 28, 2025
Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
July 22, 2025
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
July 18, 2025
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 18, 2025
BullFrog AI Launches bfPREP, a New AI-Powered Data Preparation Module in Its BullFrog Data Networks Solutions Library
July 17, 2025
BullFrog AI Unveils BullFrog Data Networks™ Solutions Library, Expanding Scalable AI-Powered Biomedical Insight Platform to Large Enterprises
July 10, 2025
BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
June 20, 2025
BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients
June 12, 2025
Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23
April 17, 2025
BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial
February 27, 2025
BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week
January 9, 2025
BullFrog AI Issues Letter to Stockholders
December 26, 2024
BullFrog AI Announces Appointment of Chief Financial Officer
December 16, 2024
BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium
October 21, 2024
Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million
October 17, 2024
BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni
October 14, 2024
BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114
October 8, 2024
BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
August 25, 2024
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets
July 24, 2024
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12
May 28, 2024
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
May 15, 2024
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
April 8, 2024
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
March 7, 2024
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
February 25, 2024
BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock
February 20, 2024